A 40-year-old man with persistent asthma is on low-dose inhaled budesonide twice daily but still reports daytime symptoms three times per week and uses his reliever most days. Spirometry shows reversible airflow obstruction. According to current stepwise management recommendations, what is the most appropriate next step?